logo

Cellular Biomedicine Group Inc. (CBMG)



Trade CBMG now with
  Date
  Headline
12/28/2017 7:31:06 AM Cellular Biomedicine Closes $14.5 Mln Private Placement Offering
12/28/2017 7:30:42 AM Cellular Biomedicine Group Announces Closing Of $14.5 Mln Private Placement Offering
11/6/2017 7:23:29 AM Cellular Biomedicine, Thermo Fisher Scientific Announce Strategic Partnership To Develop Manufacturing Processes
9/22/2017 8:42:41 AM Cellular Biomedicine Group Grand Plans Grand Opening Of Its New Shanghai Facility
6/26/2017 7:31:30 AM Cellular Biomedicine Appoints Xia Meng As COO To Lead Commercialization Of CAR-T And Stem Cell Products
6/20/2017 6:03:04 AM Cellular Biomedicine Group Appoints Michael Caligiuri As Chair Of External Advisory Board
6/1/2017 6:04:10 AM Cellular Biomedicine Group To Repurchase Up To $10 Mln In Common Shares
4/10/2017 8:07:40 AM CBMG, GE Healthcare To Establish Joint Tech Labs To Develop Control Processes For Manufacture Of CAR-T And Stem Cell
3/14/2017 6:06:19 AM Cellular Biomedicine FY 16 Net Loss Allocable To Common Stock Holders $28.2 Mln Vs $19.4 Mln Last Year
2/27/2017 8:12:25 AM Cellular Biomedicine Bags $2.29 Mln Grant From The California Institute For Regenerative Medicine
1/3/2017 8:10:00 AM Cellular Biomedicine Signs Ten-year Lease Of A 113,038 Square Feet Building In Shanghai Zhangjiang High-Tech Park
12/9/2016 8:05:02 AM Cellular Biomedicine Announces Three-Month Interim Safety Data From Phase I Clinical Trial For AlloJoin
11/29/2016 7:17:34 AM Cellular Biomedicine Announces Approval, Commencement Of Patient Enrollment In China For Its CARD-1 Phase I Trial
8/9/2016 6:27:03 AM Cellular Biomedicine Q2 Net Loss Allocable To Common Stock Holders Widens To $7.2 Mln From $5 Mln Last Year
4/19/2016 8:38:36 AM Cellular Biomedicine Group Announces Closing Of $43.13 Mln Strategic Investment From Dangdai International Group